Enorama Pharma AB (publ) (STO:ERMA)

Enorama Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6.56	2.09	6.15	4.14	12.2	4.73
Cash & Short-Term Investments	6.56	2.09	6.15	4.14	12.2	4.73
Cash Growth	-31.76%	-66.11%	48.66%	-66.07%	157.71%	-67.59%
Accounts Receivable	0.73	0.21	0.02	1.95	7.06	5.07
Other Receivables	0.56	1.2	2.03	2.37	1.45	1.12
Receivables	1.28	1.41	2.05	4.32	8.5	6.18
Inventory	3.22	11.28	4.29	2.84	1.24	1.72
Prepaid Expenses	1.15	0.39	0.47	0.45	0.47	0.19
Total Current Assets	12.22	15.16	12.96	11.75	22.41	12.82
Property, Plant & Equipment	0.02	0.14	0.86	1.54	2.22	2.83
Long-Term Deferred Charges	0.34	0.59	20.56	23.43	26.3	25.26
Other Long-Term Assets	0	-	-	12	-	-
Total Assets	12.57	15.89	34.39	48.72	50.93	40.91
Accounts Payable	2.42	1.17	3.72	5.35	2.18	1.92
Accrued Expenses	2.23	1.5	4.02	2.04	2.24	1.75
Current Portion of Long-Term Debt	-	-	0.13	1.46	2.09	1.94
Current Income Taxes Payable	-	-	0.29	0.43	0.39	0.33
Other Current Liabilities	12.58	5.43	2.06	3.14	4.79	12.68
Total Current Liabilities	17.22	8.09	10.22	12.43	11.68	18.61
Long-Term Debt	-	-	0.3	0.45	1.7	3.77
Other Long-Term Liabilities	-	-	4.33	4.33	16.2	16.75
Total Liabilities	17.22	8.09	14.85	17.2	29.58	39.13
Common Stock	11.66	9.45	6.39	1.46	1.2	0.92
Additional Paid-In Capital	270.15	237.99	205.32	176.55	126.45	79.3
Retained Earnings	-286.45	-239.64	-192.18	-149.07	-106.29	-78.44
Comprehensive Income & Other	-	-	-	2.58	-	-
Shareholders' Equity	-4.65	7.8	19.54	31.52	21.35	1.78
Total Liabilities & Equity	12.57	15.89	34.39	48.72	50.93	40.91
Total Debt	-	-	0.44	1.91	3.79	5.71
Net Cash (Debt)	6.56	2.09	5.72	2.23	8.41	-0.98
Net Cash Growth	-29.31%	-63.53%	156.37%	-73.49%	-	-
Net Cash Per Share	0.10	0.04	0.21	0.28	1.36	-0.18
Filing Date Shares Outstanding	74.59	60.47	40.93	25.86	7.69	5.91
Total Common Shares Outstanding	74.59	60.47	40.93	9.35	7.69	5.91
Working Capital	-5	7.07	2.75	-0.67	10.73	-5.79
Book Value Per Share	-0.06	0.13	0.48	3.37	2.78	0.30
Tangible Book Value	-4.65	7.8	19.54	31.52	21.35	1.78
Tangible Book Value Per Share	-0.06	0.13	0.48	3.37	2.78	0.30
Machinery	-	2.15	3.37	3.37	3.37	3.19
Construction In Progress	-	-	-	-	-	0.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.